Pateclizumab

Pateclizumab (MLTA3698A) is an immunomodulator. It binds to lymphotoxin alpha. Pateclizumab (MLTA3698A) is an immunomodulator. It binds to lymphotoxin alpha. This drug was developed by Genentech/Roche.